Retraction
Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy
Paper Information
Record ID:
50243
Author(s):
Journal:
Cancer Science
(
Wiley
)
Publication Date:
March 04, 2020
Retraction Date:
December 11, 2023
(1.9 year years ago)
Subjects:
Institutions:
- Department of Abdominal Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
- Department of Biochemistry, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
- Department of Surgery, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
- Department of Anesthesiology, Center for the Study of Itch, Washington University School of Medicine, St. Louis, MO, USA
Countries:
Article Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (42)
42
Total Citations5
Post-Retraction(11.9%)
37
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
561
Days since retraction (latest)
<sup>68</sup>Ga/<sup>161</sup>Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
Yu Zhang, Qingqing Li, Fengling Shan et al. (10 authors)
ACS Omega
Open Access
Published: Jun 2025
561 days after retraction
USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14
Leilei Li, Zhili Fan, Mengfei Liu et al. (11 authors)
Journal of Biological Chemistry
Open Access
Published: Jan 2025
387 days after retraction
Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma
Lanqian Su, Huanyu Luo, Yalan Yan et al. (10 authors)
Frontiers in Pharmacology
Open Access
Published: Jun 2024
7 citations
7 citations
192 days after retraction
Roles of USP1 in Ewing sarcoma
Panneerselvam Jayabal, Xiuye Ma, Yuzuru Shiio
Genes & Cancer
Open Access
Published: Feb 2024
2 citations
2 citations
53 days after retraction
The emerging roles of histone demethylases in cancers
Dali Tong, Ying Tang, Peng Zhong
Cancer and Metastasis Reviews
Published: Jan 2024
12 citations
12 citations
36 days after retraction
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide
Jaimie S. Gray, Sajad A. Wani, Shahid Hussain et al. (11 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2023
3 citations
3 citations
24 days before retraction
Targeting deubiquitinases for cancer therapy
Qian Xue, Daolin Tang, Xin Chen et al. (4 authors)
Clinical and Translational Discovery
Open Access
Published: Sep 2023
5 citations
5 citations
90 days before retraction
USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target
Shuang Li, Yang Song, Kexin Wang et al. (14 authors)
Cell Death Discovery
Open Access
Published: Sep 2023
14 citations
14 citations
95 days before retraction
USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma
Halle J. Mallard, Shibiao Wan, Prakriti Nidhi et al. (17 authors)
Molecular Cancer Research
Open Access
Published: Jul 2023
9 citations
9 citations
143 days before retraction
The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica
Open Access
Published: Jun 2023
10 citations
10 citations
182 days before retraction
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
Peng Huang, Yuhan Wang, Pengfei Zhang et al. (4 authors)
Clinical and Experimental Medicine
Published: Apr 2023
16 citations
16 citations
231 days before retraction
The crosstalk between ubiquitination and endocrine therapy
Yidong Ge, Ziqing Zhan, Meng Ye et al. (4 authors)
Journal of Molecular Medicine
Published: Mar 2023
2 citations
2 citations
262 days before retraction
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
Guan–Jun Yang, Changyun Li, Tao Fan et al. (9 authors)
Genes & Diseases
Open Access
Published: Mar 2023
14 citations
14 citations
263 days before retraction
Peer Review #2 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Feb 2023
298 days before retraction
Peer Review #3 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Feb 2023
298 days before retraction
Peer Review #1 of "Ubiquitin specific peptidases and prostate cancer (v0.1)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Feb 2023
298 days before retraction
Peer Review #3 of "Ubiquitin specific peptidases and prostate cancer (v0.2)"
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Feb 2023
298 days before retraction
Ubiquitin specific peptidases and prostate cancer
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen et al. (5 authors)
PeerJ
Open Access
Published: Feb 2023
10 citations
10 citations
298 days before retraction
Analysis of Protein Degradation in Ferroptosis
Zhuojun Zhang, Lili Jiang
Methods in molecular biology
Published: Jan 2023
344 days before retraction
Epigenetic regulator KDM4A activates Notch1-NICD-dependent signaling to drive tumorigenesis and metastasis in breast cancer
Jing Pei, ShengQuan Zhang, Xiaowei Yang et al. (9 authors)
Translational Oncology
Open Access
Published: Dec 2022
10 citations
10 citations
345 days before retraction
Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC
Longhao Wang, Tao Hu, Zhibo Shen et al. (14 authors)
Cell Death and Disease
Open Access
Published: Nov 2022
27 citations
27 citations
396 days before retraction
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma
Xi-Ya Li, Jichuan Wu, Ping Liu et al. (27 authors)
Leukemia
Open Access
Published: Nov 2022
20 citations
20 citations
397 days before retraction
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
Jill V. Hunter, A. Campbell, Nicola Hannaway et al. (21 authors)
Biochemical Journal
Open Access
Published: Oct 2022
9 citations
9 citations
423 days before retraction
Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction
Jinhui Guo, Jie Zhao, Litao Sun et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
10 citations
10 citations
511 days before retraction
Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation
Chao Wei, Xiangui Deng, Shudi Gao et al. (5 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jul 2022
7 citations
7 citations
518 days before retraction
Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management
Yihao Liao, Diansheng Zhou, Pu Wang et al. (5 authors)
Cell Death Discovery
Open Access
Published: Jun 2022
18 citations
18 citations
542 days before retraction
ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
Yaxin Sun, Beibei Sha, Wenjing Huang et al. (14 authors)
APOPTOSIS
Published: Jun 2022
17 citations
17 citations
557 days before retraction
Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen–mediated attenuation of stemness
Zhe Lü, Zhuo Zhang, Min Yang et al. (4 authors)
Anti-Cancer Drugs
Published: Mar 2022
7 citations
7 citations
628 days before retraction
The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
Rongfu Tu, Junpeng Ma, Peng Zhang et al. (8 authors)
Cancer Cell International
Open Access
Published: Mar 2022
10 citations
10 citations
631 days before retraction
Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells
Jing Xiong, Meifang Nie, Chun Fu et al. (7 authors)
Stem Cells International
Open Access
Published: Mar 2022
30 citations
30 citations
646 days before retraction
Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Hae-Seul Choi, Kwang‐Hyun Baek
Cellular and Molecular Life Sciences
Open Access
Published: Feb 2022
15 citations
15 citations
678 days before retraction
Ubiquitin-specific protease 1 overexpression indicates poor prognosis and promotes proliferation, migration, and invasion of gastric cancer cells
Debin Meng, Delong Li
Tissue and Cell
Published: Dec 2021
15 citations
15 citations
712 days before retraction
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry
Sandra Sanchez‐Roige, Pierre Fontanillas, Mariela Jennings et al. (34 authors)
Molecular Psychiatry
Open Access
Published: Nov 2021
51 citations
51 citations
770 days before retraction
Mechanism, specificity, and function of FANCD2‐FANCI ubiquitination and deubiquitination
Kimon Lemonidis, Connor Arkinson, Martin L. Rennie et al. (4 authors)
FEBS Journal
Open Access
Published: Jun 2021
31 citations
31 citations
907 days before retraction
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry
Sandra Sanchez‐Roige, Pierre Fontanillas, Mariela Jennings et al. (10 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2021
4 citations
4 citations
921 days before retraction
Targeting the Hippo Pathway in Prostate Cancer: What’s New?
Kelly Coffey
Cancers
Open Access
Published: Feb 2021
13 citations
13 citations
1040 days before retraction
Mechanistic insights into KDM4A driven genomic instability
Nicolas L. Young, Ruhee Dere
Biochemical Society Transactions
Open Access
Published: Jan 2021
24 citations
24 citations
1050 days before retraction
Histone lysine demethylases and their functions in cancer
Jayden Sterling, Sharleen V. Menezes, Ramzi H. Abbassi et al. (4 authors)
International Journal of Cancer
Open Access
Published: Oct 2020
76 citations
76 citations
1136 days before retraction
RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway
Shanshan Sun, Fujun Yang, Yongcun Zhu et al. (4 authors)
Life Sciences
Published: Sep 2020
21 citations
21 citations
1169 days before retraction
Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
Giacomo Canesin, Annalisa Di Ruscio, Mailin Li et al. (19 authors)
Cell Reports
Open Access
Published: Sep 2020
44 citations
44 citations
1196 days before retraction
The role of deubiquitinating enzymes in cancer drug resistance
Parthasaradhireddy Tanguturi, Kye-Seong Kim, Suresh Ramakrishna
Cancer Chemotherapy and Pharmacology
Published: Mar 2020
40 citations
40 citations
1374 days before retraction
RETRACTED: Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy
Shuzhong Cui, Ziying Lei, Tianpei Guan et al. (9 authors)
Cancer Science
Open Access
Published: Mar 2020
42 citations
42 citations
1376 days before retraction
Quick Stats
Total Citations:
42
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025